OmniAb, Inc. logo OABI - OmniAb, Inc.

NEXT EARNINGS: Mar 4, 2026 (in 7 days) EPS Est: $-0.08 | Rev Est: $9.0M
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $4.00 DETAILS
HIGH: $4.00
LOW: $4.00
MEDIAN: $4.00
CONSENSUS: $4.00
UPSIDE: 131.21%
Market Cap: 186.19M
Volume: 145,257
Avg Volume: 455,036
52 Week Range: 1.22-3.785
Sector: Healthcare
Industry: Biotechnology
Beta: 0.85
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 114
IPO Date: 2021-09-30
EPS (TTM): -0.61
P/E Ratio: -5.84
Revenue (TTM): 26.39M
Total Assets: 325.56M
Total Debt: 23.16M
Cash & Equiv: 27.60M
Rev Growth (5Y): 7.6%
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -24.0%
Debt/Equity: 0.08

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-04 $-0.14 $-0.14 -2.9% $2.2M $5.6M -60.3%
2025-08-06 $-0.15 $-0.14 -7.1% $3.9M $5.6M -31.0%
2025-05-08 $-0.17 $-0.17 0.0% $4.2M $4.5M -7.5%
2025-03-18 $-0.12 $-0.13 +7.7% $10.8M $6.5M +65.3%
2024-11-12 $-0.16 $-0.14 -14.3% $4.2M $10.1M -58.8%
2024-08-08 $-0.13 $-0.18 +27.8% $7.6M $5.8M +32.2%
2024-05-09 $-0.19 $-0.17 -11.8% $3.8M $5.9M -35.2%
2024-03-20 $-0.14 $-0.17 +17.6% $4.8M $7.5M -35.4%

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019
Revenue 26.39M 34.16M 59.08M 34.75M 23.27M 18.32M
Net Income (62.03M) (50.62M) (22.33M) (27.04M) (17.56M) (13.59M)
EPS -0.61 -0.51 -0.26 -0.24 -0.15 -0.12
Total Assets 325.56M 375.23M 421.21M 304.46M 295.38M 262.32M
Total Debt 23.16M 25.56M 25.80M 13.85M 2.59M 2.58M
Cash & Equivalents 27.60M 16.36M 33.39M 0 0 0
Operating Cash Flow (39.66M) 2.35M (3.59M) (5.67M) 3.62M (5.20M)
Free Cash Flow (41.54M) 703,000 (20.75M) (9.74M) 1.87M (5.45M)
FCF per Share -0.41 0.01 -0.24 -0.08 0.02 -0.05
Book Value 287.62M 314.58M 341.37M 234.31M 235.54M 218.19M
Cash & ST Investments 59.43M 86.98M 88.27M 0 0 0
ROC Equity -0.22 -0.16 -0.07 -0.12 -0.07 -0.06